Premium
Investing
Two agri-stars
Here are two great-looking stocks from the agricultural sector that appear well-positioned right now.
Latest Articles
Premium
Investing
Two cheap property stocks
I’ve taken a look at the property sector and found two property-related stocks that haven’t performed well on the share market in recent times. What I’ve found is that some brokers believe the market is failing to understand the story well enough.
Premium
Investing
Two under 50 cents
Opportunities are plentiful in the Australian share market’s ‘micro-cap’ space. James Dunn looks at two companies from vastly different businesses, valued at virtually the same capitalisation, with what looks to be excellent prospects, and share prices capable of pushing up through the 50-cent level.
Premium
Investing
Two ‘similar sounding’ stars
Recently I came across these two stocks, that both start with the same letter, and sound very similar when spoken aloud. But they have three other things in common, as well. Read on…
Premium
Investing
Here are two global tech leaders
Here are two ASX global leaders, both of which operate in specialist global technology fields, where they are very highly regarded: Appen and Audinate. I urge you to have a read.
Premium
Investing
4 attractive gas juniors
Australia’s east coast continues to face a potential natural gas supply deficit, that’s likely to hurt both households and industries that use gas in industrial processes. Potential new sources are working hard to address this supply gap. Here are four enterprising hydrocarbon juniors on the ASX doing just that.
Premium
Investing
Three stocks that have prospects of a 50% gain
Here’s a trio of micro-caps, in very different industries, that all look highly capable of delivering a 50% gain from current levels.
Premium
Investing
Three stocks under 50 cents
Here’s another collection of highly interesting stocks, laden with potential, from very different industries – but all currently under 50 cents in price.
Premium
Investing
Three cancer stocks
Cancer is one of the most interesting areas of work of the ASX’s growing cohort of life sciences companies. Here are three of the fascinating stories emerging from this area.
Premium
Investing
3 stocks under $20
Here are three stocks poised to smash through the $20 level in share price – in the cases of Orica and Northern Star, heading back above $20.